Riskpilot← Back to searchSign inGet full accessGSK EIENDOM AS
ASActiveOrg 991313583Langoddveien 23, 1367 SnarøyaDevelopment of building projects · NACE 6812Est. 20070 employees
Revenue 2024
NOK 0
EBITDA margin
—
-4% vs 2023
Equity ratio
-708.3%
Financial strength
Net profit 2024
NOK -23K
-4% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -23K | -4% |
| Net profit | NOK -23K | -4% |
| Total assets | NOK 198K | -2% |
| Equity | NOK -1,4M | -4908% |
| Employees | 0 | — |
Legal name
GSK EIENDOM AS
Org number
991313583
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
7. juni 2007
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringer av enhver art, samt deltakelse i andre selskaper.
Address
Langoddveien 23, 1367 Snarøya
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −3 | −4 | −7 | −22 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −4 | −7 | −22 | −23 |
| Net financials | 0 | 0 | 0 | 0 | −0 |
| Profit before tax | −3 | −4 | −7 | −22 | −23 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −4 | −7 | −22 | −23 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 | 2 | 206 | 203 | 198 |
| Equity | 5 | 1 | −6 | −28 | −1 401 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 212 | 231 | 1 599 |
| Total debt | 1 | 1 | 212 | 231 | 1 599 |
EBITDA margin
-2312200.0%
This company
15.8%
Market median
-14634277% vs market
20202024
Equity ratio
-708.3%
This company
38.2%
Market median
-1954% vs market
20202024
Return on equity
-2314200.0%
This company
18.4%
Market median
-12577274% vs market
20202024
Net profit margin
-2314200.0%
This company
8.1%
Market median
-28570470% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SK Deputy Member | Deputy Member | 2007 |
GS Chief Executive Officer | Chief Executive Officer | 2007 |
SK Deputy Member | Deputy Member | 2007 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GSK EIENDOM AS 
TENORVEIEN EIENDOM ASBoard members of GSK EIENDOM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Silje Kristine Kvam | Deputy Member | 0 companies |
| Geir Ståle Karlsen | Chief Executive Officer | 0 companies |
| Silje Kristine Karlsen | Deputy Member | 0 companies |